Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Panbela Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 20 | 9 | −11 |
| Shares | 1.94M | 410.9K | −1.53M (−78.8%) |
| Value | $857.7K | $945.1K | +$87.4K (+10.2%) |
New holders (2)
Institutions that held Panbela Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 94,536 | $217.4K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,713 | $8.54K | 0.00% |
Sold out (13)
Institutions that held Panbela Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CVI Holdings, LLC | 394,901 | $174.6K |
| Altium Capital Management LP | 335,324 | $148.3K |
| Anson Funds Management LP | 163,024 | $72.1K |
| HRT Financial LP | 68,549 | $30.0K |
| State Street Corp | 53,142 | $23.5K |
| Two Sigma Securities, LLC | 48,050 | $21.2K |
| Warberg Asset Management LLC | 20,000 | $8.80K |
| Moneta Group Investment Advisors LLC | 11,999 | $5.31K |
| HighTower Advisors, LLC | 10,185 | $5.00K |
| Two Sigma Investments, LP | 10,043 | $4.44K |
| Commonwealth Equity Services, LLC | 10,000 | $4.00K |
| Northwestern Mutual Wealth Management Co | 15 | $7 |
| Royal Bank of Canada | 12 | $0 |